Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916302288> ?p ?o ?g. }
- W2916302288 endingPage "70" @default.
- W2916302288 startingPage "62" @default.
- W2916302288 abstract "Affordable point-of-care tests for hepatitis C (HCV) viraemia are needed to improve access to treatment in low- and middle-income countries. Our aims were to determine the target limit of detection (LOD) necessary to diagnose the majority of people with HCV eligible for treatment, and identify characteristics associated with low-level viraemia (LLV) (defined as the lowest 3% of the distribution of HCV RNA) to understand those at risk of being misdiagnosed.We established a multi-country cross-sectional dataset of first available quantitative HCV RNA measurements linked to demographic and clinical data. We excluded individuals on HCV treatment. We analysed the distribution of HCV RNA and determined critical thresholds for detection of HCV viraemia. We then performed logistic regression to evaluate factors associated with LLV, and derived relative sensitivities for significant covariates.The dataset included 66,640 individuals with HCV viraemia from across the world. The LOD for the 95th and 99th percentiles were 3,311 IU/ml and 214 IU/ml. The LOD for the 97th percentile was 1,318 IU/ml (95% CI 1,298.4-1,322.3). Factors associated with LLV, defined as HCV RNA <1,318 IU/ml, were younger age 18-30 vs. 51-64 years (odds ratios [OR] 2.56; 95% CI 2.19-2.99), female vs. male sex (OR 1.32; 95% CI 1.18-1.49), and advanced fibrosis stage F4 vs. F0-1 (OR 1.44; 95% CI 1.21-1.69). Only the younger age group had a decreased relative sensitivity below 95%, at 93.3%.In this global dataset, a test with an LOD of 1,318 IU/ml would identify 97% of viraemic HCV infections among almost all populations. This LOD will help guide manufacturers in the development of affordable point-of-care diagnostics to expand HCV testing and linkage to care in low- and middle-income countries.We created and analysed a dataset from 12 countries with 66,640 participants with chronic hepatitis C virus infection. We determined that about 97% of those with viraemic infection had 1,300 IU/ml or more of circulating virus at the time of diagnosis. While current diagnostic tests can detect as little as 12 IU/ml of virus, our findings suggest that increasing the level of detection closer to 1,300 IU/ml would maintain good test accuracy and will likely enable development of more affordable portable tests for use in low- and middle-income countries." @default.
- W2916302288 created "2019-03-02" @default.
- W2916302288 creator A5004240064 @default.
- W2916302288 creator A5008730024 @default.
- W2916302288 creator A5013244136 @default.
- W2916302288 creator A5017457860 @default.
- W2916302288 creator A5022367224 @default.
- W2916302288 creator A5027739167 @default.
- W2916302288 creator A5035151513 @default.
- W2916302288 creator A5041007479 @default.
- W2916302288 creator A5045447716 @default.
- W2916302288 creator A5054840982 @default.
- W2916302288 creator A5058664398 @default.
- W2916302288 creator A5062545400 @default.
- W2916302288 creator A5069935144 @default.
- W2916302288 creator A5078526061 @default.
- W2916302288 creator A5079171066 @default.
- W2916302288 creator A5081511017 @default.
- W2916302288 creator A5084570185 @default.
- W2916302288 date "2019-07-01" @default.
- W2916302288 modified "2023-09-30" @default.
- W2916302288 title "Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset" @default.
- W2916302288 cites W1748737970 @default.
- W2916302288 cites W1964147946 @default.
- W2916302288 cites W1977300462 @default.
- W2916302288 cites W1987645096 @default.
- W2916302288 cites W1995851329 @default.
- W2916302288 cites W2012549102 @default.
- W2916302288 cites W2031131325 @default.
- W2916302288 cites W2042063943 @default.
- W2916302288 cites W2062135550 @default.
- W2916302288 cites W2064387090 @default.
- W2916302288 cites W2076395093 @default.
- W2916302288 cites W2088337379 @default.
- W2916302288 cites W2096497201 @default.
- W2916302288 cites W2106975444 @default.
- W2916302288 cites W2113729156 @default.
- W2916302288 cites W2119510460 @default.
- W2916302288 cites W2122156007 @default.
- W2916302288 cites W2126205829 @default.
- W2916302288 cites W2144076650 @default.
- W2916302288 cites W2185218296 @default.
- W2916302288 cites W2239032355 @default.
- W2916302288 cites W2261526891 @default.
- W2916302288 cites W2294032921 @default.
- W2916302288 cites W2410859412 @default.
- W2916302288 cites W2468286545 @default.
- W2916302288 cites W2516395986 @default.
- W2916302288 cites W2519436096 @default.
- W2916302288 cites W2519533902 @default.
- W2916302288 cites W2524249329 @default.
- W2916302288 cites W2534316534 @default.
- W2916302288 cites W2560439682 @default.
- W2916302288 cites W2578013986 @default.
- W2916302288 cites W2605906203 @default.
- W2916302288 cites W2736740976 @default.
- W2916302288 cites W2740941400 @default.
- W2916302288 cites W2765202013 @default.
- W2916302288 cites W2766360815 @default.
- W2916302288 cites W2766419442 @default.
- W2916302288 cites W2795927900 @default.
- W2916302288 doi "https://doi.org/10.1016/j.jhep.2019.02.011" @default.
- W2916302288 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7014921" @default.
- W2916302288 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30797050" @default.
- W2916302288 hasPublicationYear "2019" @default.
- W2916302288 type Work @default.
- W2916302288 sameAs 2916302288 @default.
- W2916302288 citedByCount "15" @default.
- W2916302288 countsByYear W29163022882019 @default.
- W2916302288 countsByYear W29163022882020 @default.
- W2916302288 countsByYear W29163022882021 @default.
- W2916302288 countsByYear W29163022882022 @default.
- W2916302288 countsByYear W29163022882023 @default.
- W2916302288 crossrefType "journal-article" @default.
- W2916302288 hasAuthorship W2916302288A5004240064 @default.
- W2916302288 hasAuthorship W2916302288A5008730024 @default.
- W2916302288 hasAuthorship W2916302288A5013244136 @default.
- W2916302288 hasAuthorship W2916302288A5017457860 @default.
- W2916302288 hasAuthorship W2916302288A5022367224 @default.
- W2916302288 hasAuthorship W2916302288A5027739167 @default.
- W2916302288 hasAuthorship W2916302288A5035151513 @default.
- W2916302288 hasAuthorship W2916302288A5041007479 @default.
- W2916302288 hasAuthorship W2916302288A5045447716 @default.
- W2916302288 hasAuthorship W2916302288A5054840982 @default.
- W2916302288 hasAuthorship W2916302288A5058664398 @default.
- W2916302288 hasAuthorship W2916302288A5062545400 @default.
- W2916302288 hasAuthorship W2916302288A5069935144 @default.
- W2916302288 hasAuthorship W2916302288A5078526061 @default.
- W2916302288 hasAuthorship W2916302288A5079171066 @default.
- W2916302288 hasAuthorship W2916302288A5081511017 @default.
- W2916302288 hasAuthorship W2916302288A5084570185 @default.
- W2916302288 hasBestOaLocation W29163022882 @default.
- W2916302288 hasConcept C105795698 @default.
- W2916302288 hasConcept C122048520 @default.
- W2916302288 hasConcept C126322002 @default.
- W2916302288 hasConcept C142724271 @default.
- W2916302288 hasConcept C151956035 @default.
- W2916302288 hasConcept C156957248 @default.